Skip to main content

Table 2 Baseline characteristics of the patients: Demographics, self-reported symptoms (KOOS), DCE-MRI perfusion variables, and physical function

From: Exercise-induced pain changes associate with changes in muscle perfusion in knee osteoarthritis: exploratory outcome analyses of a randomised controlled trial

 

Exercise therapy group

Control group

Randomised (n = 31)

Per-protocol (n = 16)

Randomised (n = 29)

Per-protocol (n = 17)

Mean (SD)

Mean (SD)

Mean (SD)

Mean (SD)

Demographic Characteristics

 Age (years)

65.9 (8.5)

67.2 (8.2)

61.3 (7.1)

60.6 (7.2)

 Female, no (%)

27 (87)

14 (87.5)

21 (71)

12 (70.6)

 Height (m)

1.69 (0.08)

1.67 (0.07)

1.72 (0.09)

1.72 (0.11)

 Weight (kg)

81.9 (14.1)

77.3 (8.3)

83.3 (15.0)

85.8 (14.2)

 BMI (kg/m2)

28.7 (4.2)

27.7 (3.4)

28.1 (4.5)

29.0 (4.0)

KOOS

 Pain

56.5 (14.8)

52.8 (18.1)

63.3 (12.4)

61.3 (9.8)

 Symptoms

58.3 (16.8)

57.4 (18.2)

65.5 (19.5)

63.9 (17.8)

 Function in Daily Living

65.0 (14.0)

61.9 (17.3)

74.2 (13.9)

76.3 (10.9)

 Knee-Related Quality of Life

27.6 (19.2)

37.9 (15.6)

34.7 (20.9)

44.1 (16.8)

 Function in Sports and Recreation

37.1 (14.2)

25.0 (16.0)

44.2 (14.4)

37.4 (23.0)

DCE-MRI Perfusion variables

 Total Muscle VOI

  Nvoxel%

–

56.1 (15.7)

–

57.7(14.7)

  IRExNvoxel

–

334.0 (171.5)

–

386.7 (230.2)

  IRExNvoxel%

–

0.30 (0.15)

–

0.18 (0.07)

  MExNvoxel

–

81,491.0 (26,054.0)

–

91,236.6 (29,556.8)

  MExNvoxel%

–

72.8 (21.5)

–

73.4 (20.7)

 Extensor VOI

  Nvoxel%

–

48.6 (16.0)

–

45.0 (19.5)

  IRExNvoxel

–

98.1 (82.5)

–

113.0 (108.9)

  IRExNvoxel%

–

0.39 (0.21)

–

0.4 (0.3)

  MExNvoxel

–

16,553.4 (9817.4)

–

16,488.1 (10,599.5)

  MExNvoxel%

–

67.1 (23.7)

–

60.6 (27.5)

 Flexor VOI

  Nvoxel%

–

58.1 (16.6)

–

60.9 (13.8)

  IRExNvoxel

–

236.1 (116.1)

–

273.7(150.0)

  IRExNvoxel%

–

0.27 (0.15)

–

0.28 (0.16)

  MExNvoxel

–

64,937.5 (17,987.4)

–

74,748.5 (21,639.4)

  MExNvoxel%

–

74.3 (22.3)

–

76.5 (19.3)

Physical function

 Muscle strength Knee extension, Nm

  0°/s

–

103.1 (21.2)

–

124.1 (35.7)

  60°/s

–

81.2 (24.8)

–

91.0 (29.9)

  120°/s

–

69.3 (20.7)

–

86.9 (29.1)

  180°/s

–

60.3 (17.0)

–

76.9 (26.8)

 Muscle strength knee flexion, Nm

  0°/s

–

48.7 (17.3)

–

63.4 (22.8)

  60°/s

–

38.1 (14.6)

–

49.0 (20.0)

  120°/s

–

34.2 (13.8)

–

45.4 (19.7)

  180°/s

–

32.4 (12.1)

–

44.1 (17.9)

 6-min walk distance, m

–

494.4 (93.8)

–

541.2 (84.7)

  1. Abbreviations: SD Standard deviation, BMI Body mass index, KOOS The Knee Injury and Osteoarthritis Outcome Score, DCE-MRI Dynamic contrast enhanced magnetic resonance imaging, Total Muscle VOI A volume of interest consisting of the summed and averaged peri-articular knee extensor and flexor muscle ROIs, Extensor VOI A volume of interest consisting of summed and averaged ROIs of the peri-articular knee extensor muscles, Flexor VOI A volume of interest consisting of summed and averaged ROIs of the peri-articular knee flexor muscles, Nvoxel% Proportion of Highly Perfused Voxels (%), IRExNvoxel Initial Rate of Enhancement Composite Score, IRExNvoxel% Initial Rate of Enhancement Index, MExNvoxel Maximal Enhancement Composite Score, MExNvoxel% Maximal Enhancement index